Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading.Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.Merus shares jumped 38.2% to $95.21 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersSteakholder Foods Ltd – ADR (NASDAQ: STKH) rose 92% to $8.32 in pre-market trading. Steakholder Foods recently announced signing of agreement for the acquisition ...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.Following the market opening Thursday, the Dow traded down 0.50% to 45,889.75 while the NASDAQ fell 1.38% to 22,187.39. The S&P 500 also fell, dropping, 0.94% to 6,575.35.Check This Out: This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For WednesdayLeading and Lagging SectorsConsumer staples shares jumped by 0.5% on Thursday.In trading on Thursday, communication services stocks fell by 1.5%.To ...